Hip2 interacts with cyclin B1 and promotes its degradation through the ubiquitin proteasome pathway

被引:13
作者
Bae, Yoonhee [1 ]
Choi, Dongwon [1 ]
Rhim, Hyangshuk [2 ]
Kang, Seongman [1 ]
机构
[1] Korea Univ, Grad Sch Life Sci & Biotechnol, Seoul 136701, South Korea
[2] Catholic Univ Korea, Coll Med, Res Inst Mol Genet, Seoul 137701, South Korea
关键词
Hip2; Cyclin B1; Ubiquitination; Apoptosis; CONJUGATING ENZYME; CHAIN SYNTHESIS; EXPRESSION; APOPTOSIS; DESTRUCTION; SYSTEM; CELL;
D O I
10.1016/j.febslet.2010.10.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hip2, a ubiquitin conjugating enzyme, is involved in the suppression of cell death. The present study revealed that Hip2 regulates the stability of the apoptotic and cell cycle regulator cyclin B1. Hip2 was found to interact with cyclin B1 to promote its degradation through the ubiquitin proteasome pathway. As a result, Hip2 significantly blocked cell death induced by the cyclin B1 protein, suggesting that Hip2 is involved in the regulation of cyclin B1-mediated cell death. Structured summary: MINT-8045218, MINT-8045231: Hip2 (uniprotkb:P61086) physically interacts (MI:0915) with cyclin-B1 (uniprotkb:P14635) by pull down (MI: 0096) (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:4505 / 4510
页数:6
相关论文
共 21 条
[1]   Hip2 interacts with and destabilizes Smac/DIABLO [J].
Bae, Yoonhee ;
Kho, Chang Won ;
Lee, Soo Young ;
Rhim, Hyangshuk ;
Kang, Seongman .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (04) :718-723
[2]   Mitotic entry - A matter of oscillating destruction [J].
Bassermann, F ;
Peschel, C ;
Duyster, J .
CELL CYCLE, 2005, 4 (11) :1515-1517
[3]  
CHEN ZJ, 1990, J BIOL CHEM, V265, P21835
[4]   Temporal and spatial control of cyclin B1 destruction in metaphase [J].
Clute, P ;
Pines, J .
NATURE CELL BIOLOGY, 1999, 1 (02) :82-87
[5]  
COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782
[6]   Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy [J].
Gomez, Lourdes A. ;
de las Pozas, Alicia ;
Reiner, Teresita ;
Burnstein, Kerry ;
Perez-Stable, Carlos .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (05) :1534-1543
[7]   Mechanisms and regulation of the degradation of cyclin B [J].
Hershko, A .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1389) :1571-1575
[8]   Protein degradation or regulation: Ub the judge [J].
Hochstrasser, M .
CELL, 1996, 84 (06) :813-815
[9]   Targeting the ubiquitin system in cancer therapy [J].
Hoeller, Daniela ;
Dikic, Ivan .
NATURE, 2009, 458 (7237) :438-444
[10]   Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme [J].
Kalchman, MA ;
Graham, RK ;
Xia, G ;
Koide, HB ;
Hodgson, JG ;
Graham, KC ;
Goldberg, YP ;
Gietz, RD ;
Pickart, CM ;
Hayden, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19385-19394